» Articles » PMID: 38892705

An Examination into the Effects of a Nutraceutical Supplement on Cognition, Stress, Eye Health, and Skin Satisfaction in Adults with Self-Reported Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial

Overview
Journal Nutrients
Date 2024 Jun 19
PMID 38892705
Authors
Affiliations
Soon will be listed here.
Abstract

: Dietary quality and the consumption of antioxidant-rich foods have been shown to protect against memory decline. Therefore, this double-blind, randomized, placebo-controlled study aimed to investigate the effects of a nutritional supplement on changes in cognitive performance. : In adults aged 40 to 70 years with subjective memory complaints, participants were randomly allocated to take a supplement containing vitamin E, astaxanthin, and grape juice extract daily for 12 weeks or a matching placebo. The primary outcomes comprised changes in cognitive tasks assessing episodic memory, working memory, and verbal memory. Secondary and exploratory measures included changes in the speed of information processing, attention, and self-report measures of memory, stress, and eye and skin health. Moreover, changes in plasma concentrations of brain-derived neurotrophic factor, malondialdehyde, tumor-necrosis factor-α, and interleukin-6 were measured, along with changes in skin carotenoid concentrations. : Compared to the placebo, nutritional supplementation was associated with larger improvements in one primary outcome measure comprising episodic memory ( = 0.037), but not for working memory ( = 0.418) or verbal learning ( = 0.841). Findings from secondary and exploratory outcomes demonstrated that the nutraceutical intake was associated with larger improvements in the Everyday Memory Questionnaire ( = 0.022), increased plasma brain-derived neurotrophic factor ( = 0.030), decreased plasma malondialdehyde ( = 0.040), and increased skin carotenoid concentrations ( = 0.006). However, there were no group differences in changes in the remaining outcome measures. : Twelve weeks of supplementation with a nutritional supplement was associated with improvements in episodic memory and several biological markers associated with cognitive health. Future research will be essential to extend and validate the current findings.

Citing Articles

Astaxanthin (AstaReal) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial.

Hecht K, Marwah M, Wood V, Nishida Y, Bach A, Gerson J Adv Ther. 2025; .

PMID: 40014233 DOI: 10.1007/s12325-025-03125-7.

References
1.
Azman K, Zakaria R . Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases. Int J Mol Sci. 2022; 23(12). PMC: 9224343. DOI: 10.3390/ijms23126827. View

2.
Gao L, Zhang Y, Sterling K, Song W . Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. Transl Neurodegener. 2022; 11(1):4. PMC: 8796548. DOI: 10.1186/s40035-022-00279-0. View

3.
Lakhan R, Sharma M, Batra K, Beatty F . The Role of Vitamin E in Slowing Down Mild Cognitive Impairment: A Narrative Review. Healthcare (Basel). 2021; 9(11). PMC: 8625211. DOI: 10.3390/healthcare9111573. View

4.
Cook S, Marsiske M, McCoy K . The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. J Geriatr Psychiatry Neurol. 2009; 22(2):103-9. PMC: 2913129. DOI: 10.1177/0891988708328214. View

5.
Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, Anan Y . A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly. Front Aging Neurosci. 2014; 6:69. PMC: 3995061. DOI: 10.3389/fnagi.2014.00069. View